Novel nude mice model of human NK/T cell lymphoma were established by subcutaneously injecting two NK/T cell lymphoma cell lines into the right axillary region of mice and successful passages were completed by injecting cell suspension which was obtained through a 70-μm cell strainer. These mice models and corresponding cell clones have been successfully developed for more than 8 generations. The survival rates of both resuscitation and transplantation in NKYS and YT models were 90% and 70% correspondingly. Pathologically, the tumour cells in all passages of the lymphoma-bearing mice and cell lines obtained from tumours were parallel to initial cell lines. Immunologically, the tumour cells expressed the characteristics of the primary and essential NK/T lymphomas. The novel mice models maintained the essential features of human NK/T cell lymphoma, and they would be ideal tools in vivo for further research of human NK/T cell lymphoma.
passages have various advantages over cell lines in vitro and single mouse models that have no passage in lymphoma research in vivo. It is not only an efficient in vivo platform to investigate drug efficacy and resistance studies in various cancers, but likely to be applied to lymphoma therapy. There is a growing need for mouse models that have stable characteristics to mimic in vivo studies of NK/T cell lymphomas. Here we introduce two NK/T cell lymphoma mouse models we have established successfully.
| MATERIALS AND METHODS

| Cell lines
The human NK/T cell lymphoma cell lines YT and NKYS were gifts and NKYS-luciferase were maintained in RPMI1640 supplemented with 10% FBS and 100 IU/mL rhIL-2. All cells were incubated at 37°C in a humidified atmosphere containing 5% CO 2 .
| Nude mice model establishing
Three-to four-week-old female BALB/c (nu/nu) nude mice and NOD/ SCID mice were bought from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China), weighed approximately 15-20 g, fed in the specific pathogen-free (SPF) barrier system and provided sterile food and water. All procedures were performed under aseptic condition. Before animal experiment, mice were fed adaptively for 1 week in the new circumstances and cyclophosphamide (CTX) for 2 days before cell suspension injection and transplantation.
Cells were washed repeatedly in Hank's liquid, resuspended in 0.2 mL RPMI1640 culture media and subcutaneously injected into the right axillary region of mice (NKYS cells in NOD/SCID mice and YT cells in nude mice). The NKYS models were injected with 20 000 IU/kg rhIL-2 once a week intraperitoneally. The general condition and the appearance changes of the lymphoma bearing mice were observed every day, and the size of tumour was measured in length and width three times a week. As soon as the tumour reached about 2000 mm 3 in size or 1.0-2.0 cm at length, or the animal showed distress, the mouse was killed. A part of the tumour tissues was used for continuous transplantation, the remaining part was divided into two parts, one for routine morphologic observation and the other preserved in liquid nitrogen for further use.
| Bioluminescent imaging
To investigate whether the tumour existed in other part of mice, tumour development was quantified by in vivo imaging using an IVIS 
| Passage
A period of time after cell suspension injection (at least 35 days in NKYS cells and 45 days in YT cells), the tumour-bearing mice (denoted F0) were killed. We took the passage in three ways initially.
Inserting the small block from the tumour into the next mice is the first. However, both the tumorigenecity and growth rate were quite low, so lastly we abandoned this method. A part of tissues excised from the tumour were minced and strained through a 70-μm cell 
| Time course engraftment analyses after transplantation
To investigate the pattern of engraftment and proliferation of the lymphoma cells in the mouse models, time-lapse engraftment analyses were performed. After subcutaneous injection of 2.0 × 10 7 tumour cells in the right axillary region of mice, tumour engraftment, and proliferation patterns were analysed every 3 days.
| Histopathology and immunophenotype
For histological examination, an autopsy was performed on each pas- 
| In situ hybridization
Epstein Barr virus (EBV) encoded EBV-encoded RNA in situ hybridization (RISH) was performed to detect RNA transcripts of EBV using 
| Flow cytometry (FCM) analysis
To evaluate surface antigens associated with cell adhesion and with the cell of origin as the normal counterpart of the tumour cells, FCM analyses were performed using the target antigens including CD2, CD3, CD4, CD5, CD7, CD8, CD45, CD56, CD57, and Ki-67. All antibodies were 
| Statistical analysis
Two-tailed t tests of equal variance were used to analyse flow cytometry data. Bioluminescence was evaluated using unpaired t tests. Statistical significance was defined as a P value of less than or equal to 0.05. All statistical analyses were done by using Prism 5. and the growth curve in the last passage is shown in Figure S1 .
| Tissue pathologic features
The cells in the process of passage had the same feature with the original cell lines. In YT and its serial passage mice models tissues, the normal architecture was effaced, heterogeneous lymphocytes diffused into the plate, with big volume and abundant cytoplasm.
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| 1511
The karyotype in cells is irregular and the chromatin is coarse. apoptotic and necrotic tumour cells were found (Figure 1 ). The tumour tissues in YT F0, YT F5 and YT F7were positive for CD56, Granzyme B, Perforin (Figure 2 ) but negative for TiA1 (Table 1) .
Sections of the biopsy from serial NKYS cell mice models showed similar morphological features with YT mouse model tissues ( Figure 3 ). Immunohistochemical staining showed the large atypical cells were positive for CD56, Granzyme B, Perforin, TiA1 ( Figure 4 and Table 1 ).
All characteristics in both kinds of biopsies are consistent with NK/T cell lymphoma. The expression of cell surface markers is summarized in Table 1 .
| Cell lines features
In and Table 2 ). Similar to YT cells, the serial NKYS F0, NKYS F4, NKYS F7 cells were CD3−/CD4−/CD7+/CD8−/CD45+/CD56+/CD57−. No difference existed between passages ( Figure 6 and Table 2 ).
| EBV infection
EBV was strongly detected in situ hybridization for EBV RNA using the EBER probe in YT, NKYS, and later passage tissues (Figures 7   and 8 ; Table 1 ).
| DISCUSSION
In vitro studies have always been a powerful tool to characterize many cancer-associated processes. However, the tumours comprise not only the malignant cells but also a plethora of nonmalignant cells and extracellular matrix-the tumour microenvironment, 11 that's why numerous aspects of neoplastic growth are difficult to model in vitro alone. In vitro approach has limitations when we extrapolate to the more complex in vivo scenario. 12 In vivo strategies are expected to only some Japanese established SNK6-which is a NK/T cell lymphoma cell line-mouse model in NOG mice, which is a similar species to NSG. 24, 25 It is known that using NSG and NOG mice to establish models costs too much, meanwhile because of the patent problem, many enthusiastic researchers have not the opportunity to use them.
Therefore, if we could find one economic and efficient way to attain the same aim, that will benefit more researchers in the world. Fortunately, we have filled the historical blank with NK/T cell lymphoma mouse models, and in vivo passage makes it possible to screen and evaluate the novel antitumour drugs in NK/T cell lymphoma.
It was reported that there is some discrepancy in different passage of mouse models, for instance, Metildi et al 26 we invent a method to establish the NK/T mice model. CTX is necessary before injecting and implanting so that the immune system of mice can be inhibited more thoroughly. However, NKYS model is still hard to establish. In terms that NKYS cell line is dependent on IL-2, We hypnosis that the tumour need IL-2 to grow. It is critical that the tumour itself need the same environment with the corresponding cell line. In the future, the mouse models will facilitate the preclinical research of NK/T cell lymphoma.
However, using cell lines as inoculum an IL-2 support does barely reflect "real world" inter-patient heterogeneity of the lymphomas because the subcutaneously injected cells did not disseminate beyond the injection site. That is a world-wild question and there is a long way to go in the research on establishing mouse models that can mimic the real tumour environment in patients.
